Review
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
Abstract (2190)
|
Core Tip (1935)
|
Full Article (HTML) (17120)
|
Figures (1-3) (571)
|
Tables (1-5) (573)
|
Full Article (PDF)-1451K (1333)
|
Peer-Review Report-94K (424)
|
Answering Reviewers-72K (352)
|
Received: 06/26/2014
|
Revised: 09/09/2014
|
Accepted: 10/10/2014
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (64)
|
Total Visits (31667)
|
Similar Articles (8)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
Abstract (2157)
|
Core Tip (1783)
|
Full Article (HTML) (9864)
|
Figures (1-1) (1041)
|
Tables (1-3) (505)
|
Full Article (PDF)-1210K (809)
|
Peer-Review Report-98K (391)
|
Answering Reviewers-99K (315)
|
Received: 07/01/2014
|
Revised: 08/01/2014
|
Accepted: 09/17/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (20779)
|
Similar Articles (168)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
Abstract (1942)
|
Core Tip (1769)
|
Full Article (HTML) (10200)
|
Figures (1-4) (1529)
|
Tables (1-1) (519)
|
Full Article (PDF)-1374K (1155)
|
Peer-Review Report-105K (358)
|
Answering Reviewers-58K (451)
|
Received: 07/28/2014
|
Revised: 08/29/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (21905)
|
Similar Articles (7)
|
Timeline of Article Publication (3)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
Abstract (1813)
|
Core Tip (1763)
|
Full Article (HTML) (7978)
|
Figures (1-3) (665)
|
Full Article (PDF)-2317K (889)
|
Peer-Review Report-102K (356)
|
Answering Reviewers-250K (408)
|
Received: 07/28/2014
|
Revised: 10/01/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (17461)
|
Similar Articles (2)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):97-109.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.97
Abstract (1564)
|
Core Tip (1446)
|
Full Article (HTML) (6660)
|
Figures (1-1) (508)
|
Tables (1-4) (539)
|
Full Article (PDF)-1455K (759)
|
Peer-Review Report-129K (234)
|
Answering Reviewers-81K (255)
|
Received: 06/28/2014
|
Revised: 10/02/2014
|
Accepted: 11/10/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (15162)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Harnessing pharmacological knowledge for personalized medicine and pharmacotyping: Challenges and lessons learned

World J Pharmacol
3(4):110-119.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.110
Abstract (1585)
|
Core Tip (1360)
|
Full Article (HTML) (4388)
|
Figures (1-1) (497)
|
Tables (1-1) (464)
|
Full Article (PDF)-2534K (583)
|
Peer-Review Report-98K (294)
|
Answering Reviewers-19K (220)
|
Received: 06/12/2014
|
Revised: 07/03/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (13494)
|
Similar Articles (7)
|
Timeline of Article Publication (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
Abstract (1971)
|
Core Tip (1593)
|
Full Article (HTML) (9245)
|
Figures (1-2) (605)
|
Tables (1-1) (434)
|
Full Article (PDF)-1376K (830)
|
Peer-Review Report-116K (500)
|
Answering Reviewers-78K (385)
|
Received: 06/29/2014
|
Revised: 09/01/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (22136)
|
Similar Articles (71)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
Abstract (1957)
|
Core Tip (1786)
|
Full Article (HTML) (8537)
|
Figures (1-2) (490)
|
Tables (1-1) (470)
|
Full Article (PDF)-2415K (626)
|
Peer-Review Report-106K (446)
|
Answering Reviewers-72K (336)
|
Received: 06/27/2014
|
Revised: 10/02/2014
|
Accepted: 11/03/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (18)
|
Total Visits (18016)
|
Similar Articles (0)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(1)
|
Open
Minireviews
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding

World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
Abstract (1810)
|
Core Tip (1641)
|
Full Article (HTML) (6054)
|
Figures (1-1) (466)
|
Full Article (PDF)-1040K (623)
|
Peer-Review Report-104K (375)
|
Answering Reviewers-60K (292)
|
Received: 06/28/2014
|
Revised: 09/03/2014
|
Accepted: 09/24/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (14915)
|
Similar Articles (11)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
Abstract (1826)
|
Core Tip (1851)
|
Full Article (HTML) (8170)
|
Figures (1-2) (534)
|
Tables (1-1) (476)
|
Full Article (PDF)-4747K (877)
|
Peer-Review Report-116K (383)
|
Answering Reviewers-128K (387)
|
Received: 06/27/2014
|
Revised: 08/07/2014
|
Accepted: 10/29/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (6)
|
Total Visits (21258)
|
Similar Articles (2)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):174-185.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.174
Abstract (1496)
|
Core Tip (1255)
|
Full Article (HTML) (4978)
|
Tables (1-1) (500)
|
Full Article (PDF)-1054K (479)
|
Peer-Review Report-106K (331)
|
Answering Reviewers-75K (240)
|
Received: 07/29/2014
|
Revised: 10/02/2014
|
Accepted: 10/27/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (12599)
|
Similar Articles (18)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
Abstract (1783)
|
Core Tip (1381)
|
Full Article (HTML) (7883)
|
Tables (1-2) (532)
|
Full Article (PDF)-872K (719)
|
Peer-Review Report-82K (361)
|
Answering Reviewers-100K (310)
|
Received: 05/16/2014
|
Revised: 07/04/2014
|
Accepted: 09/17/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (17668)
|
Similar Articles (31)
|
Timeline of Article Publication (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Therapeutics Advances
World J Pharmacol
3(4):193-198.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.193
Abstract (1563)
|
Core Tip (1256)
|
Full Article (HTML) (2795)
|
Figures (1-2) (424)
|
Tables (1-1) (443)
|
Full Article (PDF)-1053K (434)
|
Peer-Review Report-98K (363)
|
Answering Reviewers-31K (219)
|
Received: 06/24/2014
|
Revised: 09/22/2014
|
Accepted: 10/10/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (13636)
|
Similar Articles (768)
|
Timeline of Article Publication (2)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Evidence-Based Medicine
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
Abstract (1776)
|
Core Tip (1607)
|
Full Article (HTML) (7914)
|
Tables (1-4) (599)
|
Full Article (PDF)-1067K (663)
|
Peer-Review Report-118K (339)
|
Answering Reviewers-113K (365)
|
Received: 07/28/2014
|
Revised: 09/08/2014
|
Accepted: 10/16/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (17249)
|
Similar Articles (80)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Systematic Reviews
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?

World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
Abstract (1844)
|
Core Tip (1510)
|
Full Article (HTML) (9935)
|
Figures (1-1) (516)
|
Tables (1-2) (811)
|
Full Article (PDF)-1014K (597)
|
Peer-Review Report-80K (345)
|
Answering Reviewers-67K (260)
|
Received: 05/21/2014
|
Revised: 07/14/2014
|
Accepted: 10/27/2014
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (19999)
|
Similar Articles (230)
|
Timeline of Article Publication (5)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open